Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a small backend/format update; no visible changes to the study details are expected.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a revision tag changing from v3.5.2 to v3.5.3, indicating a small administrative update to the ClinicalTrials.gov record.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedHb SS disease added under Resources and Genetic and Rare Diseases Information Center listed as a Resources reference.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.